Putnam’s Centers of Excellence allow us to dig deep, challenge convention, and take you further with strategies underpinned by technical expertise in cutting-edge topics.
A strategic thought partner for your AI journey
Explore our latest insights and perspectives in these life science resources, news articles, and events.
Health equity in pharma: Addressing disparities via diversity in trials, access to care, RWE, tech innovation, and cross-functional collaboration.
Introduction The 2024 American Society of Hematology (ASH) Annual Meeting presented a wealth of data, unveiling the...
Putnam shares key questions to consider in preparation of advancing trials and deals that have been put on hold.
Putnam predicts the 15 drugs likely to be selected for the second round of Medicare Price Negotiations.
Putnam has a proven track record of delivering superior strategic support to pharma leaders in developing strategies...
Health technology assessments (HTAs) are a crucial part of the journey to bring newly developed pharmaceuticals and medical devices to patients.
In the evolving healthcare landscape, securing market access for new treatments often depends on how effectively their efficacy and safety...
MASS West 2024 showcased key themes in health equity, AI, and Real-World Evidence, helping Medical Affairs leaders tackle evolving challenges.
As I take a moment to reflect on the past two-plus years of our AI journey and consider the predictions I made for 2024, it’s clear that many...
Putnam's Demand Calibration Tool enhances demand estimation accuracy by leveraging insights from 200+ studies across 50+ diseases and markets
We explore two instances where our consulting teams used AssetNav to help clients prioritize promising BD&L opportunities in oncology.
Looking to get in touch with an expert or team member?
Tell us how we can help.
